August 14th, 2013
Advanced Lipoprotein Analysis: Time for Widespread Implementation?
Behnood Bikdeli, M.D.
Will advanced lipoprotein analysis add real value to patients’ lives?
NEJM — Recent Cardiology Articles- Descending Thoracic Aortic Aneurysm July 16, 2026A man presented with a 2-month history of chest heaviness and a 2-week history of shortness of breath. Pulsations were visible between his ribs (shown in a video). Ultrasonography revealed a rounded structure near the heart.
- Balancing the Scales — Extended DAPT in Coronary Artery Disease July 16, 2026The appropriate duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has remained the subject of a central debate in cardiovascular medicine. DAPT is intended to mitigate ischemic risk, but its maintenance warrants balancing the benefit against the concomitant risk of hemorrhage.1 Consequently, determining the appropriate...
- Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease July 16, 2026Among patients with multivessel coronary artery disease who were in stable condition 1 year after stenting, an additional year of DAPT led to a lower risk of ischemic events than aspirin alone, without increased bleeding.
- Platelet-Activating Anti–Platelet Factor 4 Disorders July 13, 2026This review summarizes platelet-activating anti–platelet factor 4 disorders, including heparin-induced thrombocytopenia and related syndromes, highlighting diagnosis, antibody mechanisms, and treatment strategies.
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty July 12, 2026After total hip or knee arthroplasty, aspirin alone was noninferior to rivaroxaban followed by aspirin in preventing symptomatic venous thromboembolism, with a similarly low risk of bleeding complications.
- Descending Thoracic Aortic Aneurysm July 16, 2026